Results 151 to 160 of about 138,687 (371)
Corrigendum to “Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency” [Clin. Immunol. 110 (2004) 22–29]
, 2004 Pierre Quartier, Jacinta Bustamante, Özden Sanal, Alessandro Plebani, Marianne Debré, Anne Deville, Jiří Litzman, Jacov Levy, Jean‐Paul Fermand, Peter J. L. Lane, Gerd Horneff, Güzide Aksu, Işık Yalçin, Graham Davies, İlhan Tezcan, Furgen Ersoy, Nadia Catalan, Kohsuhe Imai, Alain Fischer, Anne Durandy +19 moreopenalex +1 more sourceTissue‐Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts
American Journal of Hematology, EarlyView.ABSTRACT
Although all myeloid cells are considered to derive from hematopoietic stem cells, the cells in each myeloid lineage are heterogeneous populations, and their distribution and functions vary, depending on underlying physiologic and pathologic processes, age, sex, and genetic and epigenetic signatures.Peter Valent, Johann Wojta, Petri T. Kovanen, Olivier Hermine, Falko Fend, Karl Sotlar, Hildegard Greinix, Klaus Geissler, Karin Hartmann, Juliana Schwaab, Marco Herling, Laura Boccuni, Lukas Kazianka, Max Vincent John, Wolfgang R. Sperr, Carina Zierfuss, Alexandar Tzankov, Christian Sillaber, Milen Minkov, Gregor Hoermann, Matthew Collin, Hans‐Peter Horny, Torsten Haferlach, Maria Sibilia, Julien Haroche, Paul La Rosée, Alberto Orfao, Michel Arock +27 morewiley +1 more sourceLiver Transplantation in a Patient With CD40 Ligand Deficiency and Hyper-IgM Syndrome: Clinical and Immunological Assessments
, 2016 Min‐Hua Tseng, Shili Ge, Robert L. Roberts, Caroline Y. Kuo, Jua Choi, N. Nissen, I. Kim, M. Chu, Borami Shin, Mieko Toyoda, Stanley C. Jordan +10 moreopenalex +1 more sourceEffect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects: Results From ACTG 384
Journal of Acquired Immune Deficiency Syndromes, 2006 R. Gandhi, J. Spritzler, Ellen S. Chan, D. Asmuth, B. Rodriguez, T. Merigan, M. Hirsch, R. Shafer, G. Robbins, R. Pollard +9 moresemanticscholar +1 more sourceFacts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)
American Journal of Hematology, EarlyView.ABSTRACT
D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start Armando Tripodi, Walter Ageno, Luca Barcella, Antonio Coppola, Marcello Di Nisio, Massimo Franchini, Monia Marchetti, Rossella Marcucci, Marco Marietta, Pasquale Pignatelli, Domenico Prisco, Valerio De Stefano +11 morewiley +1 more sourceVirologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited
Journal of Acquired Immune Deficiency Syndromes, 2003 A. Moore, O. Kirk, Anne M Johnson, C. Katlama, A. Blaxhult, M. Dietrich, R. Colebunders, A. Chiesi, Jens D. Lungren, A. Phillips +9 moresemanticscholar +1 more sourceCD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas
American Journal of Hematology, EarlyView.ABSTRACT
The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues.Harald Stein, Brunangelo Faliniwiley +1 more source